NADIASLY M SANTILLANO CUESTA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LAS VEGAS, NV NPI 1134595259

General Payments — all program years on this page

$763.95

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 25
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $697.01 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $697.0121

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $66.944
2024 $697.0121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086283908 Bayer Healthcare Pharmaceuticals Inc. $13.42 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100407845 Novo Nordisk Inc $22.18 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100435649 Novo Nordisk Inc $16.85 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104262491 AstraZeneca Pharmaceuticals LP $15.53 08/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104279303 AstraZeneca Pharmaceuticals LP $20.52 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104316544 AstraZeneca Pharmaceuticals LP $16.72 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104497412 AstraZeneca Pharmaceuticals LP $121.96 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105730255 AstraZeneca Pharmaceuticals LP $24.99 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105874409 AstraZeneca Pharmaceuticals LP $68.37 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108144191 ABBVIE INC. $27.99 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108144193 ABBVIE INC. $149.01 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114523204 Exact Sciences Corporation $15.90 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114523208 Exact Sciences Corporation $13.58 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114523212 Exact Sciences Corporation $13.78 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117374419 Amgen Inc. $16.00 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117886989 Boehringer Ingelheim Pharmaceuticals, Inc. $20.48 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117886991 Boehringer Ingelheim Pharmaceuticals, Inc. $33.55 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131094190 PFIZER INC. $22.16 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131293917 PFIZER INC. $16.26 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139973199 SANOFI-AVENTIS U.S. LLC $23.03 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150133929 SHIELD THERAPEUTICS INC $24.73 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.